share_log

ArriVent BioPharma Q1 EPS $(0.70) Beats $(1.05) Estimate

Benzinga ·  May 8 08:15

ArriVent BioPharma (NASDAQ:AVBP) reported quarterly losses of $(0.70) per share which beat the analyst consensus estimate of $(1.05) by 33.33 percent.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment